Ventyx Biosciences Inc (VTYX)

Ventyx Biosciences Inc (VTYX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Mar 6, 2026: market cap $1B; returns 1 week +0.2%, 1 year +803.2%.

Ventyx Biosciences is a clinical-stage biopharmaceutical company specializing in the development of oral small molecule therapeutics for inflammatory and autoimmune diseases. The company's business model is centered on its proprietary drug discovery engine which targets the innate immune system, specifically the NLRP3 inflammasome.

VTYX financial model: income statement, cash flow and balance sheet